{"id":"https://openalex.org/W7225398276","doi":"https://doi.org/10.1097/md.0000000000051470","title":"Successful rechallenge with almonertinib and corticosteroids after gefitinib-induced interstitial lung disease: A case report and literature review","display_name":"Successful rechallenge with almonertinib and corticosteroids after gefitinib-induced interstitial lung disease: A case report and literature review","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225398276","doi":"https://doi.org/10.1097/md.0000000000051470","pmid":"https://pubmed.ncbi.nlm.nih.gov/42994820"},"language":"en","primary_location":{"id":"doi:10.1097/md.0000000000051470","doi":"https://doi.org/10.1097/md.0000000000051470","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000051470","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/md.0000000000051470","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161100737","display_name":"Jie Liu","orcid":"https://orcid.org/0000-0002-3931-2445","observed_orcids":["https://orcid.org/0000-0002-3931-2445"]},"institutions":[{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jie Liu","raw_affiliation_strings":["Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China"],"raw_orcid":"https://orcid.org/0000-0002-3931-2445","affiliations":[{"raw_affiliation_string":"Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China","institution_ids":["https://openalex.org/I4210160531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005474306","display_name":"Tengchen Wei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tengchen Wei","raw_affiliation_strings":["Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China","institution_ids":["https://openalex.org/I4210160531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015622743","display_name":"Zhenming Bao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhenming Bao","raw_affiliation_strings":["Department of Respiratory and Critical Care Medicine, The 900th Hospital of the PLA Joint Logistics Support Force, Fuzhou, Fujian, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory and Critical Care Medicine, The 900th Hospital of the PLA Joint Logistics Support Force, Fuzhou, Fujian, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085658144","display_name":"Peng Lai","orcid":"https://orcid.org/0000-0001-7469-244X","observed_orcids":["https://orcid.org/0000-0001-7469-244X"]},"institutions":[{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peng Lai","raw_affiliation_strings":["Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China","institution_ids":["https://openalex.org/I4210160531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161136390","display_name":"Fangfang Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fangfang Huang","raw_affiliation_strings":["Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China","institution_ids":["https://openalex.org/I4210160531"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5161006975","display_name":"Yunhu Pan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yunhu Pan","raw_affiliation_strings":["Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory and Critical Care Medicine, The 907th Hospital of the PLA Joint Logistics Support Force, Nanping, Fujian, China","institution_ids":["https://openalex.org/I4210160531"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1950,"currency":"USD","value_usd":1950},"apc_paid":{"value":1950,"currency":"USD","value_usd":1950},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"105","issue":"45","first_page":"e51470","last_page":"e51470"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/almonertinib","display_name":"almonertinib","score":0.8629999756813049},{"id":"https://openalex.org/keywords/third-generation-egfr-tki","display_name":"third-generation EGFR-TKI","score":0.7279999852180481},{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.8690000176429749},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/egfr-l858r-mutation","display_name":"L858R mutation","score":0.9089999794960022},{"id":"https://openalex.org/keywords/methylprednisolone","display_name":"methylprednisolone","score":0.8569999933242798},{"id":"https://openalex.org/keywords/corticosteroid-prophylaxis","display_name":"corticosteroid prophylaxis","score":0.9670000076293945},{"id":"https://openalex.org/keywords/drug-induced-lung-injury","display_name":"drug-induced lung injury","score":0.7300000190734863},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8849999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9878000020980835},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7103000283241272},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5878999829292297},{"id":"https://openalex.org/C2779563347","wikidata":"https://www.wikidata.org/wiki/Q843799","display_name":"Adenocarcinoma of the lung","level":4,"score":0.5576000213623047},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5503000020980835},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.5198000073432922},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5149999856948853},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.49309998750686646},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47029998898506165},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.4697999954223633},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4546000063419342},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4514999985694885},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.4512999951839447},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4318000078201294},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.413100004196167},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.38190001249313354},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.36660000681877136},{"id":"https://openalex.org/C2780372218","wikidata":"https://www.wikidata.org/wiki/Q417222","display_name":"Methylprednisolone","level":2,"score":0.3433000147342682},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3089999854564667},{"id":"https://openalex.org/C2776330896","wikidata":"https://www.wikidata.org/wiki/Q1634800","display_name":"Telangiectasia","level":2,"score":0.3027999997138977},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2996000051498413},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29660001397132874},{"id":"https://openalex.org/C2776779939","wikidata":"https://www.wikidata.org/wiki/Q1479485","display_name":"Hypoxemia","level":2,"score":0.2955999970436096},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2822999954223633},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.27950000762939453},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.27889999747276306},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.2728999853134155},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26589998602867126},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.26010000705718994},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.2563000023365021}],"mesh":[{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077192","descriptor_name":"Adenocarcinoma of Lung","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017563","descriptor_name":"Lung Diseases, Interstitial","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D017563","descriptor_name":"Lung Diseases, Interstitial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/md.0000000000051470","doi":"https://doi.org/10.1097/md.0000000000051470","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000051470","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},{"id":"pmid:42994820","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42994820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1097/md.0000000000051470","doi":"https://doi.org/10.1097/md.0000000000051470","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000051470","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1913616561","https://openalex.org/W2119919210","https://openalex.org/W2593986306","https://openalex.org/W2890155867","https://openalex.org/W3119032247","https://openalex.org/W3164436791","https://openalex.org/W3166021199","https://openalex.org/W4280558216","https://openalex.org/W4295079305","https://openalex.org/W4308953088","https://openalex.org/W4386283206","https://openalex.org/W4391173881","https://openalex.org/W4395670357","https://openalex.org/W4399328928","https://openalex.org/W4400512400","https://openalex.org/W4405128252","https://openalex.org/W4405624923","https://openalex.org/W4407022122","https://openalex.org/W4413803535"],"related_works":["https://openalex.org/W2593986306","https://openalex.org/W1481440133","https://openalex.org/W4414096059","https://openalex.org/W2015874289","https://openalex.org/W2108645452","https://openalex.org/W4400512400","https://openalex.org/W2022402336","https://openalex.org/W3166021199","https://openalex.org/W2100278074","https://openalex.org/W4391173881"],"abstract_inverted_index":{"RATIONALE:":[0],"First-generation":[1],"epidermal":[2],"growth":[3],"factor":[4],"receptor":[5],"(EGFR)":[6],"tyrosine":[7],"kinase":[8],"inhibitors":[9],"(TKIs)":[10],"are":[11,56],"highly":[12],"effective":[13],"in":[14,84,255],"EGFR-mutant":[15],"non-small":[16],"cell":[17],"lung":[18,24,75,138],"cancer":[19],"(NSCLC);":[20],"however,":[21],"drug-induced":[22],"interstitial":[23],"disease":[25,189],"(ILD)":[26],"remains":[27],"a":[28,61,209,249,276],"rare":[29],"but":[30,283],"potentially":[31],"fatal":[32],"adverse":[33],"event.":[34],"The":[35,112,203,215],"safety":[36,285],"and":[37,59,95,108,153,191,212,225,261,269],"efficacy":[38],"of":[39,87,100,125,148,228,232],"EGFR-TKI":[40],"rechallenge":[41],"-":[42,52,77,91],"either":[43],"with":[44,72,116,155,163,207,221,258],"the":[45,88,123,127,141,167,173,186],"same":[46],"agent":[47],"or":[48],"an":[49,81],"alternative":[50],"one":[51],"following":[53],"ILD":[54],"resolution":[55],"not":[57],"established":[58],"represent":[60,275],"significant":[62],"clinical":[63,109,278],"knowledge":[64],"gap.":[65],"PATIENT":[66],"CONCERNS:":[67],"A":[68],"53-year-old":[69],"never-smoking":[70],"woman":[71],"stage":[73],"IV":[74],"adenocarcinoma":[76,139],"detected":[78],"to":[79,132,145,180,194,201],"harbor":[80],"L858R":[82],"mutation":[83],"exon":[85],"21":[86],"EGFR":[89],"gene":[90],"developed":[92],"progressive":[93],"dyspnea":[94],"hypoxemia":[96],"after":[97],"2":[98],"months":[99,171,184,242],"first-line":[101],"gefitinib":[102],"therapy,":[103],"despite":[104],"confirmed":[105],"initial":[106],"radiographic":[107],"response.":[110],"DIAGNOSES:":[111],"patient":[113,128,142,174,187,204,216],"was":[114,129,143,175,205],"diagnosed":[115],"grade":[117],"3":[118],"gefitinib-associated":[119],"ILD.":[120,134,265],"INTERVENTIONS:":[121],"With":[122,266],"discontinuation":[124],"gefitinib,":[126],"given":[130,166,198],"methylprednisolone":[131],"resolve":[133],"To":[135],"control":[136,224],"advanced":[137],"progression,":[140],"subjected":[144],"6":[146],"cycles":[147],"treatment":[149],"using":[150],"pemetrexed,":[151],"carboplatin,":[152],"bevacizumab,":[154],"measurable":[156,218],"tumor":[157,168,219,223],"shrinkage,":[158,220],"followed":[159],"by":[160],"maintenance":[161],"therapy":[162],"bevacizumab.":[164],"Furthermore,":[165],"progression":[169,190],"14":[170],"later,":[172,185],"prescribed":[176],"docetaxel":[177],"plus":[178],"bevacizumab":[179],"restore":[181],"control.":[182],"Ten":[183],"experienced":[188],"strongly":[192],"requested":[193],"use":[195],"EGFR-TKIs":[196],"again":[197],"prior":[199,262],"response":[200],"EGFR-TKI.":[202],"rechallenged":[206],"almonertinib,":[208],"third-generation":[210],"EGFR-TKI,":[211],"methylprednisolone.":[213],"OUTCOMES:":[214],"had":[217],"sustained":[222],"no":[226],"recurrence":[227],"pulmonary":[229],"toxicity.":[230],"As":[231],"last":[233],"follow-up,":[234],"she":[235],"maintained":[236],"progression-free":[237],"survival":[238],"for":[239,280],"approximately":[240],"8":[241],"on":[243],"almonertinib.":[244],"LESSONS:":[245],"This":[246],"case":[247],"provides":[248],"hypothesis-generating":[250],"observation,":[251],"illustrating":[252],"feasibility":[253],"only":[254],"highly\u2011selected":[256],"patients":[257],"EGFR\u2011mutant":[259],"NSCLC":[260],"severe":[263],"TKI\u2011related":[264],"prophylactic":[267],"corticosteroids":[268],"rigorous":[270],"surveillance,":[271],"third\u2011generation":[272],"EGFR\u2011TKI":[273],"may":[274],"tentative":[277],"option":[279],"such":[281],"patients,":[282],"general":[284],"cannot":[286],"be":[287],"inferred":[288],"from":[289],"this":[290],"single":[291],"case.":[292]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-07T00:00:00"}